ArborGen Holdings - Key US market unaffected by COVID-19 thus far
ArborGen’s US sales appear to have fared well in H220 as management has reaffirmed guidance for FY20. While we are aware of COVID-19 risks – which...
215 Views
ArborGen Holdings - Positive actions sustaining EBIT progress
ArborGen is set to deliver good year-on-year progress in FY20 despite constrained availability of advanced seedlings due to prior year weather...
690 Views
Rubicon - Pure play, clear focus
The simplified corporate structure presents investors in Rubicon (RBC) with a pure-play, advanced forestry genetics business with leading positions...
56 Views